Abstract Myeloid malignancies exhibit considerable heterogeneity with overlapping clinical and genetic features among subtypes. We present a data-driven approach that integrates mutational features and clinical covariates at diagnosis within networks of their probabilistic relationships. enabling the discovery of patient subgroups. A key strength is its ability to include presumed cau... https://www.divivoyance.com/product-category/bond-builder/